$0.9206
0.1926.14%
In chiusura: -
$0.6734
-0.25-26.85%
After hour: 7:59 PM EDT
GT Biopharma segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di GT Biopharma utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
GTBP | GT Biopharma | -$1.53 | -$0.38 | — | — | $0.00 | — | — | — | 11/28/2025 | |
GTBP | GT Biopharma | -$2.17 | -$0.68 | -$0.55 | 19.12% | $0.00 | — | $0.00 | — | 08/14/2025 | |
GTBP | GT Biopharma | -$1.64 | — | -$0.33 | — | $0.00 | — | $0.00 | — | 05/15/2025 | |
GTBP | GT Biopharma | -$2.14 | — | -$1.66 | — | $0.00 | — | $0.00 | — | 02/21/2025 | |
GTBP | GT Biopharma | -$1.77 | — | -$1.53 | — | $0.00 | — | $0.00 | — | 11/14/2024 | |
GTBP | GT Biopharma | -$1.49 | — | -$2.17 | — | $0.00 | — | $0.00 | — | 08/14/2024 | |
GTBP | GT Biopharma | -$0.21 | -$2.70 | -$1.64 | 39.26% | $0.00 | — | $0.00 | — | 05/15/2024 | |
GTBP | GT Biopharma | -$5.40 | -$2.70 | -$2.14 | 20.74% | $0.00 | — | $0.00 | — | 03/26/2024 | |
GTBP | GT Biopharma | -$6.60 | -$3.00 | -$1.80 | 40.00% | $0.00 | — | $0.00 | — | 11/01/2023 | |
GTBP | GT Biopharma | -$3.00 | -$3.00 | -$1.50 | 50.00% | $0.00 | — | $0.00 | — | 08/07/2023 | |
GTBP | GT Biopharma | -$5.10 | -$4.20 | -$0.30 | 92.86% | $0.00 | — | $0.00 | — | 05/15/2023 | |
GTBP | GT Biopharma | -$15.60 | -$5.10 | -$5.40 | -5.88% | $0.00 | — | $0.00 | — | 03/30/2023 | |
GTBP | GT Biopharma | -$5.10 | -$3.30 | -$6.60 | -100.00% | $0.00 | — | $0.00 | — | 10/31/2022 | |
GTBP | GT Biopharma | -$4.50 | -$0.17 | -$3.00 | -1664.71% | $0.00 | — | $0.00 | — | 08/11/2022 | |
GTBP | GT Biopharma | -$54.90 | -$9.30 | -$5.10 | 45.16% | $0.00 | — | $0.00 | — | 05/16/2022 | |
GTBP | GT Biopharma | -$102.00 | -$6.30 | -$15.60 | -147.62% | $0.00 | — | $0.00 | — | 03/28/2022 | |
GTBP | GT Biopharma | -$19.20 | -$6.30 | -$5.10 | 19.05% | $0.00 | — | $0.00 | — | 11/10/2021 | |
GTBP | GT Biopharma | — | -$8.40 | -$4.50 | 46.43% | — | — | $0.00 | — | 08/23/2021 | |
GTBP | GT Biopharma | — | — | -$54.90 | — | — | — | $0.00 | — | 05/17/2021 | |
GTBP | GT Biopharma | — | -$7.20 | -$102.00 | -1316.67% | — | — | $0.00 | — | 04/19/2021 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-0.55 | $-0.68 | 19.1 % |
| Q1 | 2024-05-15 | $-1.64 | $-2.70 | 39.3 % |
| Q4 | 2024-03-26 | $-2.14 | $-2.70 | 20.7 % |
| Q3 | 2023-11-01 | $-1.80 | $-3.00 | 40.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
Si prevede che GT Biopharma (GTBP) fornisca risultati il novembre 28, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
L'EPS effettivo era $-0.55, che superato la stima di $-0.68.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.